Chmp 1A is a mediator of the anti-proliferative effects of All-trans Retinoic Acid in human pancreatic cancer cells

Molecular Cancer

Volumn 8, Issue , 2009, Pages

  Li, Jing ^a   Orr, Brandon ^a   White, Kayla ^a   Belogortseva, Natalia ^a   Niles, Richard ^a   Boskovic, Goran ^a   Nguyen, Hanh ^a   Dykes, Ava ^a   Park, Maiyon ^a  

^a MARSHALL UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CELLULAR RETINOL BINDING PROTEIN 1; CHARGED MULTIVESICULAR PROTEIN 1A; CHROMATIN MODIFYING PROTEIN 1A; PROTEIN P53; RETINOIC ACID; SERINE; SHORT HAIRPIN RNA; TUMOR SUPPRESSOR PROTEIN; UNCLASSIFIED DRUG; CELLULAR RETINOL BINDING PROTEIN; CHMP1 PROTEIN, HUMAN; NUCLEAR PROTEIN; PHOSPHOPROTEIN;

ARTICLE; CANCER CELL; CANCER INHIBITION; CELL MEMBRANE; CELL PROLIFERATION; CELL STRAIN HEK293; CONFOCAL MICROSCOPY; CONTROLLED STUDY; DNA MICROARRAY; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; IN VITRO STUDY; NUCLEOTIDE SEQUENCE; PANCREAS CANCER; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; WESTERN BLOTTING; CELL NUCLEUS; DRUG EFFECT; METABOLISM; PANCREAS CARCINOMA; PANCREAS TUMOR; PATHOLOGY; PROTEIN TRANSPORT; TUMOR CELL LINE;

CARCINOMA, PANCREATIC DUCTAL; CELL LINE, TUMOR; CELL NUCLEUS; CELL PROLIFERATION; HUMANS; NUCLEAR PROTEINS; PANCREATIC NEOPLASMS; PHOSPHOPROTEINS; PROTEIN TRANSPORT; RETINOL-BINDING PROTEINS, CELLULAR; TRETINOIN; TUMOR SUPPRESSOR PROTEIN P53;

EID: 62749098755     PISSN: None     EISSN: 14764598     Source Type: Journal    
DOI: 10.1186/1476-4598-8-7     Document Type: Article

References (50)

1. Ross AC Retinoid production and catabolism: Role of diet in regulating retinol esterification and retinoic Acid oxidation J Nutr 2003, 133:291S-296S. 12514312
2. Ross AC Zolfaghari R Regulation of hepatic retinol metabolism: perspectives from studies on vitamin A status J Nutr 2004, 134:269S-275S. 14704332
3. Niles RM Signaling pathways in retinoid chemoprevention and treatment of cancer Mutat Res 2004, 555:81-96. 15476854
4. Fields AP Frederick LA Regala RP Targeting the oncogenic protein kinase Ciota signalling pathway for the treatment of cancer Biochem Soc Trans 2007, 35:996-1000. 10.1042/BST0350996 17956262
5. De Luca LM Retinoids and their receptors in differentiation, embryogenesis, and neoplasia Faseb J 1991, 5:2924-2933. 1661245
6. Altucci L Rossin A Raffelsberger W Reitmair A Chomienne C Gronemeyer H Retinoic acid-induced apoptosis in leukemia cells is mediated by paracrine action of tumor-selective death ligand TRAIL Nat Med 2001, 7:680-686. 10.1038/89050 11385504
7. Noy N Retinoid-binding proteins: Mediators of retinoid action Biochem J 2000, 348(Pt 3):481-495. 1221089 10839978 10.1042/0264-6021:3480481
8. Farias EF Ong DE Ghyselinck NB Nakajo S Kuppumbatti YS Mira y Lopez R Cellular retinol-binding protein I, a regulator of breast epithelial retinoic acid receptor activity, cell differentiation, and tumorigenicity J Natl Cancer Inst 2005, 97:21-29. 15632377
9. Farias EF Marzan C Mira-y-Lopez R Cellular retinol-binding protein-I inhibits PI3K/Akt signaling through a retinoic acid receptor-dependent mechanism that regulates p85-p110 heterodimerization Oncogene 2005, 24:1598-1606. 10.1038/sj.onc.1208347 15608670
10. Kuppumbatti YS Bleiweiss IJ Mandeli JP Waxman S Mira YLR Cellular retinol-binding protein expression and breast cancer J Natl Cancer Inst 2000, 92:475-480. 10.1093/jnci/92.6.475 10716965
11. Haupt Y Maya R Kazaz A Oren M Mdm2 promotes the rapid degradation of p53 Nature 1997, 387:296-299. 10.1038/387296a0 9153395
12. Kastan MB Wild-type p53: Tumors can't stand it Cell 2007, 128:837-840. 10.1016/j.cell.2007.02.022 17350571
13. Levine AJ p53, the cellular gatekeeper for growth and division Cell 1997, 88:323-331. 10.1016/S0092-8674(00)81871-1 9039259
14. Finlay CA Hinds PW Levine AJ The p53 proto-oncogene can act as a suppressor of transformation Cell 1989, 57:1083-1093. 10.1016/ 0092-8674(89)90045-7 2525423
15. Malkin D Li FP Strong LC Fraumeni JF Jr Nelson CE Kim DH Kassel J Gryka MA Bischoff FZ Tainsky MA et al Germ line p53 mutations in a familial syndrome of breast cancer, sarcomas, and other neoplasms Science 1990, 250:1233-1238. 10.1126/science.1978757 1978757
16. Hurley JH ESCRT complexes and the biogenesis of multivesicular bodies Curr Opin Cell Biol 2008, 20:4-11. 2282067 18222686 10.1016/ j.ceb.2007.12.002
17. Li FP Fraumeni JF Jr Soft-tissue sarcomas, breast cancer, and other neoplasms. A familial syndrome? Ann Intern Med 1969, 71:747-752. 5360287
18. Howard TL Stauffer DR Degnin CR Hollenberg SM CHMP1 functions as a member of a newly defined family of vesicle trafficking proteins J Cell Sci 2001, 114:2395-2404. 11559748
19. Stauffer DR Howard TL Nyun T Hollenberg SM CHMP1 is a novel nuclear matrix protein affecting chromatin structure and cell-cycle progression J Cell Sci 2001, 114:2383-2393. 11559747
20. Park IK Morrison SJ Clarke MF Bmi1, stem cells, and senescence regulation J Clin Invest 2004, 113:175-179. 311443 14722607
21. Nowak K Kerl K Fehr D Kramps C Gessner C Killmer K Samans B Berwanger B Christiansen H Lutz W BMI1 is a target gene of E2F-1 and is strongly expressed in primary neuroblastomas Nucleic Acids Res 2006, 34:1745-1754. 1421501 16582100 10.1093/nar/gkl119
22. Li J Belogortseva N Porter D Park M Chmp1A functions as a novel tumor suppressor gene in human embryonic kidney and ductal pancreatic tumor cells Cell Cycle 2008, 7:2886-2893. 18787405
23. Bardeesy N DePinho RA Pancreatic cancer biology and genetics Nat Rev Cancer 2002, 2:897-909. 10.1038/nrc949 12459728
24. Ulrich AB Schmied BM Standop J Schneider MB Pour PM Pancreatic cell lines: A review Pancreas 2002, 24:111-120. 10.1097/ 00006676-200203000-00001 11854615
25. Warrell RP Jr Frankel SR Miller WH Jr Scheinberg DA Itri LM Hittelman WN Vyas R Andreeff M Tafuri A Jakubowski A et al Differentiation therapy of acute promyelocytic leukemia with tretinoin (all-trans-retinoic acid) N Engl J Med 1991, 324:1385-1393. 1850498
26. Smith MA Parkinson DR Cheson BD Friedman MA Retinoids in cancer therapy J Clin Oncol 1992, 10:839-864. 1569455
27. Bug G Ritter M Wassmann B Schoch C Heinzel T Schwarz K Romanski A Kramer OH Kampfmann M Hoelzer D et al Clinical trial of valproic acid and all-trans retinoic acid in patients with poor-risk acute myeloid leukemia Cancer 2005, 104:2717-2725. 10.1002/cncr.21589 16294345
28. Arapshian A Bertran S Kuppumbatti YS Nakajo S Mira-y-Lopez R Epigenetic CRBP downregulation appears to be an evolutionarily conserved (human and mouse) and oncogene-specific phenomenon in breast cancer Mol Cancer 2004, 3:13. 419713 15113415 10.1186/1476-4598-3-13
29. Guo JM Xiao BX Lou YR Wang DH Yan CH Zhan L Zhao WH The effects of all-trans-retinoic acid on cell cycle and alkaline phosphatase activity in pancreatic cancer cells Med Chem 2006, 2:457-461. 10.2174/ 157340606778250298 17017984
30. Guo J Xiao B Lou Y Yan C Zhan L Wang D Zhao W Antitumor effects of all-trans-retinoic acid on cultured human pancreatic cancer cells J Gastroenterol Hepatol 2006, 21:443-448. 10.1111/j.1440-1746.2006.04180.x 16509872
31. El-Metwally TH Hussein MR Pour PM Kuszynski CA Adrian TE High concentrations of retinoids induce differentiation and late apoptosis in pancreatic cancer cells in vitro Cancer Biol Ther 2005, 4:602-611. 15970678
32. El-Metwally TH Hussein MR Pour PM Kuszynski CA Adrian TE Natural retinoids inhibit proliferation and induce apoptosis in pancreatic cancer cells previously reported to be retinoid resistant Cancer Biol Ther 2005, 4:474-483. 15908778
33. El-Metwally TH Hussein MR Abd-El-Ghaffar S Abo-El-Naga MM Ulrich AB Pour PM Retinoic acid can induce markers of endocrine transdifferentiation in pancreatic ductal adenocarcinoma: Preliminary observations from an in vitro cell line model J Clin Pathol 2006, 59:603-610. 10.1136/ jcp.2005.032003 16473924
34. Sipos B Moser S Kalthoff H Torok V Lohr M Kloppel G A comprehensive characterization of pancreatic ductal carcinoma cell lines: Towards the establishment of an in vitro research platform Virchows Arch 2003, 442:444-452. 12692724
35. Lieber M Mazzetta J Nelson-Rees W Kaplan M Todaro G Establishment of a continuous tumor-cell line (panc-1) from a human carcinoma of the exocrine pancreas Int J Cancer 1975, 15:741-747. 10.1002/ijc.2910150505 1140870
36. Seewaldt VL Dietze EC Johnson BS Collins SJ Parker MB Retinoic Acid-mediated G1-S-Phase Arrest of Normal Human Mammary Epithelial Cells Is Independent of the Level of p53 Protein Expression Cell Growth Differ 1999, 10:49-59. 9950218
37. Mrass P Rendl M Mildner M Gruber F Lengauer B Ballaun C Eckhart L Tschachler E Retinoic acid increases the expression of p53 and proapoptotic caspases and sensitizes keratinocytes to apoptosis: A possible explanation for tumor preventive action of retinoids Cancer Res 2004, 64:6542-6548. 10.1158/0008-5472.CAN-04-1129 15374966
38. Rodriguez A Diez C Caamano JN de Frutos C Royo LJ Munoz M Ikeda S Facal N Alvarez-Viejo M Gomez E Retinoid receptor-specific agonists regulate bovine in vitro early embryonic development, differentiation and expression of genes related to cell cycle arrest and apoptosis Theriogenology 2007, 68:1118-1127. 10.1016/j.theriogenology.2007.08.007 17869331
39. Rosewicz S Stier U Brembeck F Kaiser A Papadimitriou CA Berdel WE Wiedenmann B Riecken EO Retinoids: Effects on growth, differentiation, and nuclear receptor expression in human pancreatic carcinoma cell lines Gastroenterology 1995, 109:1646-1660. 10.1016/0016-5085(95)90655-X 7557150
40. Huang Y Minigh J Miles S Niles RM Retinoic acid decreases ATF-2 phosphorylation and sensitizes melanoma cells to taxol-mediated growth inhibition J Mol Signal 2008, 3:3. 2265711 18269766 10.1186/1750-2187-3-3
41. Nilsson A Troen G Petersen LB Reppe S Norum KR Blomhoff R Retinyl ester storage is altered in liver stellate cells and in HL60 cells transfected with cellular retinol-binding protein type I Int J Biochem Cell Biol 1997, 29:381-389. 10.1016/S1357-2725(96)00068-4 9147140
42. Jeronimo C Henrique R Oliveira J Lobo F Pais I Teixeira MR Lopes C Aberrant cellular retinol binding protein 1 (CRBP1) gene expression and promoter methylation in prostate cancer J Clin Pathol 2004, 57:872-876. 1770387 15280411 10.1136/jcp.2003.014555
43. Roberts D Williams SJ Cvetkovic D Weinstein JK Godwin AK Johnson SW Hamilton TC Decreased expression of retinol-binding proteins is associated with malignant transformation of the ovarian surface epithelium DNA Cell Biol 2002, 21:11-19. 10.1089/10445490252810276 11879576
44. Orlandi A Ferlosio A Ciucci A Francesconi A Lifschitz-Mercer B Gabbiani G Spagnoli LG Czernobilsky B Cellular retinol binding protein-1 expression in endometrial hyperplasia and carcinoma: Diagnostic and possible therapeutic implications Mod Pathol 2006, 19:797-803. 16575402
45. Eskild W Troen G Blaner WS Nilsson A Hansson V Evidence for independent control at the mRNA and protein levels of cellular retinol binding protein 1 in rat Sertoli cells J Reprod Fertil 2000, 119:101-109. 10.1530/reprod/119.1.101 10864819
46. Browman DT Hoegg MB Robbins SM The SPFH domain-containing proteins: More than lipid raft markers Trends Cell Biol 2007, 17:394-402. 10.1016/ j.tcb.2007.06.005 17766116
47. Riecken EO Rosewicz S Retinoids in pancreatic cancer Ann Oncol 1999, 10(Suppl 4):197-200. 10.1023/A:1008319121622 10436821
48. Orlandi A Bianchi L Costanzo A Campione E Giusto Spagnoli L Chimenti S Evidence of increased apoptosis and reduced proliferation in basal cell carcinomas treated with tazarotene J Invest Dermatol 2004, 122:1037-1041. 10.1111/j.0022-202X.2004.22414.x 15102095
49. Oren M Regulation of the p53 tumor suppressor protein J Biol Chem 1999, 274:36031-36034. 10.1074/jbc.274.51.36031 10593882
50. Fernandes ND Sun Y Price BD Activation of the kinase activity of ATM by retinoic acid is required for CREB-dependent differentiation of neuroblastoma cells J Biol Chem 2007, 282:16577-16584. 10.1074/ jbc.M609628200 17426037